Published in World J Gastroenterol on April 28, 2014
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology (2015) 1.85
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance. Onco Targets Ther (2016) 1.14
Tumor-infiltrating dendritic cells in cancer pathogenesis. J Immunol (2015) 0.87
Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore) (2015) 0.86
Causes and consequences of microsatellite instability in gastric carcinogenesis. World J Gastroenterol (2014) 0.86
Competing endogenous RNA networks and gastric cancer. World J Gastroenterol (2015) 0.85
Opisthorchiasis: an overlooked danger. PLoS Negl Trop Dis (2015) 0.84
Gastric biomarkers: a global review. World J Surg Oncol (2016) 0.79
Th22 cell accumulation is associated with colorectal cancer development. World J Gastroenterol (2015) 0.77
MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2. Cancer Gene Ther (2015) 0.77
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes. J Diabetes Complications (2015) 0.77
Site-specific fibroblasts regulate site-specific inflammatory niche formation in gastric cancer. Gastric Cancer (2015) 0.77
Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes. J Inflamm Res (2015) 0.76
Effect of interleukin-1β and tumor necrosis factor α gene silencing on mouse gastric cancer cell proliferation and migration. Oncol Lett (2016) 0.76
Evaluation of selected interleukins in patients with different gastric neoplasms: a preliminary report. Sci Rep (2015) 0.76
Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5. Sci Rep (2016) 0.75
HER-2-induced PI3K signaling pathway was involved in the pathogenesis of gastric cancer. Cancer Gene Ther (2015) 0.75
Changing the natural history of metachronous gastric cancer after H. pylori eradication. Jpn J Helicobacter Res (2015) 0.75
Proteolysis in Helicobacter pylori-Induced Gastric Cancer. Toxins (Basel) (2017) 0.75
NF-κB Signaling in Gastric Cancer. Toxins (Basel) (2017) 0.75
Genetic Alterations in Gastric Cancer Associated with Helicobacter pylori Infection. Front Med (Lausanne) (2017) 0.75
Differentiating malignant from benign gastric mucosal lesions with quantitative analysis in dual energy spectral computed tomography: Initial experience. Medicine (Baltimore) (2017) 0.75
Cutting Edge: Helicobacter pylori Induces Nuclear Hypersegmentation and Subtype Differentiation of Human Neutrophils In Vitro. J Immunol (2017) 0.75
Monitoring of the Immune Dysfunction in Cancer Patients. Vaccines (Basel) (2016) 0.75
IL-32α-induced inflammation constitutes a link between obesity and colon cancer. Oncoimmunology (2017) 0.75
The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer. Oncol Lett (2017) 0.75
Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis. Oncotarget (2017) 0.75
Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer. Gastric Cancer (2016) 0.75
PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer. Oncotarget (2017) 0.75
Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology. World J Gastrointest Oncol (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Inflammation and cancer. Nature (2002) 53.78
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57
Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell (2005) 9.06
Radical causes of cancer. Nat Rev Cancer (2003) 5.45
The tumor microenvironment and its role in promoting tumor growth. Oncogene (2008) 4.66
Chronic inflammation and cancer. Oncology (Williston Park) (2002) 3.82
Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell (2009) 3.71
Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol (2006) 3.18
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother (2011) 2.97
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66
Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res (2006) 2.37
Limiting inflammatory responses during activation of innate immunity. Nat Immunol (2005) 2.33
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One (2012) 2.14
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer (2010) 2.11
Cytokines in cancer immunity and immunotherapy. Immunol Rev (2004) 2.09
STAT3 expression in gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol (2008) 1.96
Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol (2011) 1.84
Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol (2005) 1.82
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer (2013) 1.67
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer (2008) 1.62
Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology (2010) 1.55
Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect (2009) 1.53
Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol (2012) 1.50
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology (2000) 1.48
Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol (2010) 1.43
Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol (2011) 1.38
Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol (2010) 1.34
Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol (2009) 1.34
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer (2008) 1.27
Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol (2010) 1.23
Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology (2004) 1.23
Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res (2005) 1.22
Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership. Curr Cancer Drug Targets (2005) 1.20
CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology (2012) 1.16
Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses (2012) 1.12
Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer (2011) 1.12
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer (2009) 1.10
Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma. Am J Surg (2010) 1.07
Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer. J Clin Immunol (2012) 1.07
The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One (2012) 1.06
Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer (2012) 1.06
Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer. J Mol Med (Berl) (2012) 1.05
Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer. Cancer Immunol Immunother (2012) 1.05
Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Virchows Arch (2005) 1.02
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut (2011) 1.02
Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Cancer (2009) 1.01
Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment. Clin Cancer Res (2012) 1.01
Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev (2012) 1.01
Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy. World J Surg Oncol (2013) 0.99
Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol Biomarkers Prev (2011) 0.98
CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol (2011) 0.98
Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection. Int J Cancer (2011) 0.96
IL-6 serum levels predict postoperative morbidity in gastric cancer patients. Gastric Cancer (2011) 0.96
Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer (2009) 0.95
Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma. Gut (2013) 0.94
The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer. J Surg Oncol (2011) 0.94
CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis. World J Gastroenterol (2012) 0.94
The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer. Ann Surg (2009) 0.94
IL-32 expression is an independent prognostic marker for gastric cancer. Med Oncol (2013) 0.93
Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival. Dig Dis Sci (2009) 0.92
Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J Med Microbiol (2006) 0.92
Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma. Ann Surg Oncol (2008) 0.92
Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer. Oncol Rep (2010) 0.92
Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer. PLoS One (2013) 0.92
Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Ann Surg Oncol (2011) 0.91
Matrix metalloproteinase-14 is a negative prognostic marker for patients with gastric cancer. Dig Dis Sci (2013) 0.90
Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. Clin Cancer Res (2009) 0.89
Clinical impact of tumor-infiltrating CD45RO⁺ memory T cells on human gastric cancer. Oncol Rep (2013) 0.89
Hypoxia-inducible factor 1 alpha (HIF-1α) as a prognostic indicator in patients with gastric tumors: a meta-analysis. Asian Pac J Cancer Prev (2013) 0.88
Prognostic value of CCR7 expression in gastric cancer. Hepatogastroenterology (2007) 0.88
Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer. BMC Cancer (2012) 0.88
Effect of IL-1β and TNF-α polymorphisms on the prognosis and survival of gastric cancer patients. Clin Exp Med (2011) 0.88
Prognostic value of HIF-1α expression in patients with gastric cancer. Mol Biol Rep (2013) 0.88
CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer. Gastric Cancer (2011) 0.87
Inducible nitric oxide synthase, nitrotyrosine and apoptosis in gastric adenocarcinomas and their correlation with a poor survival. World J Gastroenterol (2005) 0.87
Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer. J Surg Oncol (2008) 0.86
Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol (2005) 0.85
Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers. World J Gastroenterol (2012) 0.85
Helicobacter pylori with stronger intensity of CagA phosphorylation lead to an increased risk of gastric intestinal metaplasia and cancer. BMC Microbiol (2011) 0.84
Prognostic value of CD208-positive cell infiltration in gastric cancer. Cancer Immunol Immunother (2009) 0.84
Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer. PLoS One (2013) 0.84
TLR9 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. PLoS One (2013) 0.83
Helicobacter pylori has no influence on distal gastric cancer survival. Arq Gastroenterol (2011) 0.83
Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma. BMC Cancer (2011) 0.83
The relationship between Helicobacter pylori genes cagE and virB11 and gastric cancer. Int J Infect Dis (2010) 0.82
Elevated circulating CD19+ lymphocytes predict survival advantage in patients with gastric cancer. Asian Pac J Cancer Prev (2012) 0.82
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma. Eur J Cancer (2009) 0.82
S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Proteomics Clin Appl (2012) 0.82
CD33⁺/p-STAT1⁺ double-positive cell as a prognostic factor for stage IIIa gastric cancer. Med Oncol (2013) 0.82
Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer. Med Oncol (2012) 0.81
Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Anticancer Res (2009) 0.81
Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer. Int J Clin Oncol (2008) 0.81
Prognostic significance of the local expression of interleukin-12 in patients with advanced gastric cancer. Anticancer Res (2008) 0.81
Prognostic value of CD83-positive mature dendritic cells and their relation to vascular endothelial growth factor in advanced human gastric cancer. Oncol Rep (2005) 0.81